DK146595C - Analogifremgangsmaade til fremstilling af substituerede 9-alkoxymethyl- eller -alkylthiomethylpuriner eller salte heraf - Google Patents

Analogifremgangsmaade til fremstilling af substituerede 9-alkoxymethyl- eller -alkylthiomethylpuriner eller salte heraf

Info

Publication number
DK146595C
DK146595C DK392675A DK392675A DK146595C DK 146595 C DK146595 C DK 146595C DK 392675 A DK392675 A DK 392675A DK 392675 A DK392675 A DK 392675A DK 146595 C DK146595 C DK 146595C
Authority
DK
Denmark
Prior art keywords
alcoxymethyl
alkylthiomethyl
purines
analogy
salts
Prior art date
Application number
DK392675A
Other languages
English (en)
Other versions
DK146595B (da
DK392675A (da
Inventor
Howard John Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10402412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK146595(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK392675A publication Critical patent/DK392675A/da
Publication of DK146595B publication Critical patent/DK146595B/da
Application granted granted Critical
Publication of DK146595C publication Critical patent/DK146595C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
DK392675A 1974-09-02 1975-09-01 Analogifremgangsmaade til fremstilling af substituerede 9-alkoxymethyl- eller -alkylthiomethylpuriner eller salte heraf DK146595C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3827874 1974-09-02
GB38278/74A GB1523865A (en) 1974-09-02 1974-09-02 Purine compunds and salts thereof

Publications (3)

Publication Number Publication Date
DK392675A DK392675A (da) 1976-03-03
DK146595B DK146595B (da) 1983-11-14
DK146595C true DK146595C (da) 1984-04-24

Family

ID=10402412

Family Applications (1)

Application Number Title Priority Date Filing Date
DK392675A DK146595C (da) 1974-09-02 1975-09-01 Analogifremgangsmaade til fremstilling af substituerede 9-alkoxymethyl- eller -alkylthiomethylpuriner eller salte heraf

Country Status (35)

Country Link
US (3) US4294831A (da)
JP (1) JPS5154589A (da)
AR (4) AR220299A1 (da)
AT (1) AT354462B (da)
AU (1) AU503160B2 (da)
BE (1) BE833006A (da)
BG (4) BG24815A3 (da)
CA (1) CA1062257A (da)
CH (7) CH626363A5 (da)
CS (2) CS203092B2 (da)
CY (1) CY1033A (da)
DD (1) DD122092A5 (da)
DE (1) DE2539963A1 (da)
DK (1) DK146595C (da)
ES (3) ES440631A1 (da)
FI (1) FI60709C (da)
FR (1) FR2282892A1 (da)
GB (1) GB1523865A (da)
HK (1) HK84379A (da)
HU (1) HU176730B (da)
IE (1) IE42282B1 (da)
IL (1) IL48035A (da)
KE (1) KE3002A (da)
LU (1) LU73304A1 (da)
MC (1) MC1068A1 (da)
MY (1) MY8200191A (da)
NL (1) NL175061C (da)
NO (1) NO144216C (da)
NZ (1) NZ178556A (da)
RO (4) RO74274A (da)
SE (1) SE428562C (da)
SU (7) SU904523A3 (da)
YU (4) YU39947B (da)
ZA (1) ZA755574B (da)
ZM (1) ZM12875A1 (da)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4287188A (en) 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
AU521577B2 (en) * 1977-02-24 1982-04-22 Wellcome Foundation Limited, The 9-hydroxyethoxymethyl guanine phosphates
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
JPS57102818A (en) * 1980-10-15 1982-06-26 Wellcome Found Treatment for fish virus diseases
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4603219A (en) * 1981-05-21 1986-07-29 Syntex (U.S.A.) Inc. 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for 9-(1,3-dihydroxy-2-propoxymethyl)guanine
CA1305138C (en) * 1981-08-11 1992-07-14 Howard J. Schaeffer Antiviral acyclic nucleoside derivatives and their preparation
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
EP0101441B1 (en) * 1982-02-12 1987-01-14 Syntex (U.S.A.) Inc. Anti-viral compositions
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
ATE33653T1 (de) * 1982-10-14 1988-05-15 Wellcome Found Antivirale purinderivate.
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US5059604A (en) * 1982-10-14 1991-10-22 Burroughs Wellcome Co. 2-amino purine derivatives
US4745119A (en) * 1982-10-14 1988-05-17 Burroughs Wellcome Co. Method for using purine derivatives
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
ES8403904A1 (es) * 1983-02-25 1984-04-01 Ind Farma Especial Un procedimiento para la preparacion de acicloguanosina.
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
JPS6023380A (ja) * 1983-06-24 1985-02-05 メルク・エンド・カムパニー・インコーポレーテッド 抗ウイルス剤
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体
US4918219A (en) * 1983-10-31 1990-04-17 Warner-Lambert Company Glycerine derivatives
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
ZA848080B (en) * 1983-10-31 1985-06-26 Warner Lambert Co Purine derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
IL74881A0 (en) * 1984-04-13 1985-07-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH0625061B2 (ja) 1984-07-03 1994-04-06 ザ ウエルカム フアウンデ−シヨン リミテツド 抗ウイルス性化合物
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5683990A (en) * 1985-03-16 1997-11-04 Glaxo Wellcome Inc. Treatment of human viral infections
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
EP0203736B1 (en) 1985-05-02 1989-11-23 The Wellcome Foundation Limited Antiviral compounds
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
CA1317225C (en) * 1986-10-06 1993-05-04 Robert M. Mentzer, Jr. Use of adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
EP0290630A4 (de) * 1986-11-25 1990-02-26 Inst Organicheskogo Sinteza Ak 9-substituierte guanine.
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US4835104A (en) * 1987-06-16 1989-05-30 Ajinomoto Co., Inc., Patent & Licensing Department Process for producing and purifying 2',3'-dideoxynucleosides, and process for producing 2',3'-dideoxy-2',3'-didehydronucleosides
US6306647B1 (en) 1987-06-16 2001-10-23 Ajinomoto Co., Inc. Process for producing and purifying 2′,3′-dideoxynucleosides, and process for producing 2′,3′-dideoxy-2′,3′-didehydronucleosides
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
CA1302887C (en) * 1987-11-24 1992-06-09 Yves Langelier Combination of acyclovir or a derivative thereof and bacitracin
JPH01121424U (da) * 1988-02-10 1989-08-17
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
JPH02164881A (ja) * 1988-10-24 1990-06-25 Wellcome Found Ltd:The 治療用ヌクレオシド化合物
AU626983B2 (en) * 1989-01-31 1992-08-13 Whitby Research, Inc. N6-substituted 9-methyladenines
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
GB8907173D0 (en) * 1989-03-30 1989-05-10 Beecham Group Plc Novel compounds
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
CA2091732C (en) * 1992-07-08 1998-07-21 Anica Markovac A process for the preparation of 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE59310344D1 (de) * 1992-09-24 2003-07-24 Hoechst Ag N1-Substituierte 1H-1,2,3-Triazolo[4,5-d]pyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
IT1264599B1 (it) * 1993-06-14 1996-10-04 Solar Chem Sa Processo per la sintesi della 9-(2-idrossietossimetil)- guanina
US5567816A (en) * 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
IN179493B (da) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
US5789589A (en) * 1996-04-22 1998-08-04 Drug Innovation & Design, Inc. Guanine analog phosphates
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6180790B1 (en) 1997-05-15 2001-01-30 Drug Innovation And Design, Inc. Methods of preparing acyclovir prodrugs
DE69807464T2 (de) * 1997-05-15 2003-05-15 Drug Innovation & Design Inc Diester-derivate von acyclovir
BR0213323A (pt) * 2001-10-16 2005-01-25 Avanir Pharmaceuticals Inibição viral por n-docosanol
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
EP1440072A4 (en) * 2001-10-30 2005-02-02 Conforma Therapeutic Corp PURINE ANALOGS HAVING HSP90 INHIBITORY ACTIVITY
US7078524B2 (en) 2002-11-22 2006-07-18 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
CN105596356A (zh) 2003-01-14 2016-05-25 吉里德科学公司 用于联合抗病毒治疗的组合物和方法
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
AU2005244985B2 (en) 2004-05-19 2011-09-01 Emisphere Technologies, Inc. Acyclovir formulations
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
EP2001488A4 (en) * 2006-03-14 2009-11-25 Alt Solutions Inc PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
SG194404A1 (en) 2008-12-23 2013-11-29 Gilead Pharmasset Llc Synthesis of purine nucleosides
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
WO2010075549A2 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside phosphoramidates
BR112012024884A2 (pt) 2010-03-31 2016-10-18 Gilead Pharmasset Llc síntese estereosseletiva de ativos contendo fósforo
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines

Also Published As

Publication number Publication date
YU222075A (en) 1982-08-31
CH629206A5 (de) 1982-04-15
FR2282892B1 (da) 1980-04-25
CH626364A5 (da) 1981-11-13
YU39947B (en) 1985-06-30
RO74275A (ro) 1981-09-24
AR220299A1 (es) 1980-10-31
BG26536A4 (da) 1979-04-12
NL175061C (nl) 1984-09-17
NO753009L (da) 1976-03-03
ES455979A1 (es) 1978-01-16
RO74276A (ro) 1981-06-26
RO76939A (ro) 1981-06-22
CH628897A5 (de) 1982-03-31
MY8200191A (en) 1982-12-31
ZM12875A1 (en) 1977-09-21
HU176730B (en) 1981-04-28
ATA676375A (de) 1979-06-15
NZ178556A (en) 1978-09-25
SU904523A3 (ru) 1982-02-07
CS203092B2 (en) 1981-02-27
AR220885A1 (es) 1980-12-15
KE3002A (en) 1979-12-14
CA1062257A (en) 1979-09-11
CH626363A5 (da) 1981-11-13
AU8445975A (en) 1977-03-10
US4360522A (en) 1982-11-23
SU751325A3 (ru) 1980-07-23
SE428562C (sv) 1985-08-20
NL7510342A (nl) 1976-03-04
LU73304A1 (da) 1976-08-13
RO74274A (ro) 1981-09-24
FI60709B (fi) 1981-11-30
MC1068A1 (fr) 1976-05-21
US4294831A (en) 1981-10-13
HK84379A (en) 1979-12-14
SU686618A3 (ru) 1979-09-15
SE428562B (sv) 1983-07-11
AT354462B (de) 1979-01-10
FI60709C (fi) 1982-03-10
AR220508A1 (es) 1980-11-14
ZA755574B (en) 1977-04-27
BG25094A3 (en) 1978-07-12
FI752465A (da) 1976-03-03
CS203093B2 (en) 1981-02-27
DK146595B (da) 1983-11-14
BE833006A (fr) 1976-03-02
IE42282L (en) 1976-03-02
DE2539963C2 (da) 1987-01-22
CY1033A (en) 1980-08-01
DD122092A5 (da) 1976-09-12
IL48035A (en) 1981-07-31
DK392675A (da) 1976-03-03
DE2539963A1 (de) 1976-03-18
CH623587A5 (da) 1981-06-15
YU120182A (en) 1982-08-31
US4323573A (en) 1982-04-06
IL48035A0 (en) 1975-11-25
YU40079B (en) 1985-06-30
JPS6147839B2 (da) 1986-10-21
SU799664A3 (ru) 1981-01-23
IE42282B1 (en) 1980-07-16
SE7509675L (sv) 1976-03-03
AR212914A1 (es) 1978-11-15
CH629805A5 (de) 1982-05-14
NO144216C (no) 1981-07-15
JPS5154589A (en) 1976-05-13
SU784777A3 (ru) 1980-11-30
YU119982A (en) 1982-08-31
CH623586A5 (da) 1981-06-15
FR2282892A1 (fr) 1976-03-26
YU40080B (en) 1985-06-30
NO144216B (no) 1981-04-06
ES440631A1 (es) 1977-06-16
SU700064A3 (ru) 1979-11-25
SU858569A3 (ru) 1981-08-23
AU503160B2 (en) 1979-08-23
BG24815A3 (en) 1978-05-12
GB1523865A (en) 1978-09-06
BG26389A3 (da) 1979-03-15
NL175061B (nl) 1984-04-16
YU120082A (en) 1982-08-31
ES455978A1 (es) 1978-01-16

Similar Documents

Publication Publication Date Title
DK146595C (da) Analogifremgangsmaade til fremstilling af substituerede 9-alkoxymethyl- eller -alkylthiomethylpuriner eller salte heraf
DK144942C (da) Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte
DK145341C (da) Analogifremgangsmaade til fremstilling af pyridylguanidiner
DK154289C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller salte deraf
DK144525C (da) Analogifremgangsmaade til fremstilling af 5-halogenpyrimid-2-oner eller salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK146386C (da) Analogifremgangsmaade til fremstilling af phenylalkanolamin-forbindelser eller salte deraf
DK157027C (da) Fremgangsmaade til fremstilling af 7beta-amino-3-cephem-3-o1-4-carboxylsyreforbindelser eller salte deraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK146006C (da) Fremgangsmaade til fremstilling af i 2- og 6-stillingen i phenylringen substituerede 2-phenylamino-2-imidazolin-derivater eller salte deraf
DK145907C (da) Fremgangsmaade til fremstilling af 2-arylamino-2-imidazolin-derivater eller salte deraf
DK143801C (da) Analogifremgangsmaade til fremstilling af dihydrolysergsyrederivater
DK139724C (da) Analogifremgangsmaade til fremstilling af pyridobenzodiazepinoner eller salte heraf
DK441875A (da) Fremgangsmade til fremstilling af 2-phenyliminoimidazolidiner eller syreadditionssalte deraf
DK159154C (da) Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
DK144301C (da) Analogifremgangsmaade til fremstilling af penicilliner eller salte deraf
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK127676A (da) Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf
DK147623C (da) Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf
DK146822C (da) Analogifremgangsmaade til fremstilling af derivater af 4-desacetyl-vinblastin eller salte deraf
DK140590B (da) Analogifremgangsmåde til fremstilling af 4-cyclopropylmethylenoxy-3-chlorphenyleddikesyre eller salte heraf.
DK143844C (da) Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller salte deraf
DK146127C (da) Analogifremgangsmaade til fremstilling af 5-(2-hydroxy-n-propoxy)-4-oxo-8-n-propyl-4h-1-benzopyran-2-carboxylsyre eller salte eller estre deraf
DK140841B (da) Analogifremgangsmåde til fremstilling af isoquinolinderivater eller salte deraf.
DK408176A (da) Fremgangsmade til fremstilling af 5-thiazolmethanaminderivater eller salte deraf

Legal Events

Date Code Title Description
PUP Patent expired